Experiences with
Aversion therapy17,499 public posts
Want to take advantage of all our features? Just log in!
or
2025 Spring -Information only - NHS England notification of contingent liability - COVID-19 spring 2025 vaccination programme
Please note this covers NHS England - and is information only at this time -
https://www.gov.uk/government/publications/departmental-minute-on-the-covid-19-spring-2025-vaccination-programme/departmental-minute-from-the-department-of-health-and-social-care-notification-of-contingent-liability-covid-
Wednesday's Word
[u][i]light therapy[/i][/u]
[i]This is a potential treatment for difficult to control itching. [/i]
[i]It is thought that the light therapy breaks down the irritants (bile acids possibly) that cause the itch sensation. This therapy is something you need to have a conversation with
Chemo-free treatment with acalabrutinib can benefit CLL/SLL patients never treated before: a plain language summary of the ELEVATE-TN study
The ELEVATE-TN international study commenced in September 2015. The plain language article illustrates how this clinical trial was established and run to determine whether targeted therapy arms using acalabrutinib, a Bruton's Tyrosine Kinase inhibitor ( BTKi), with or without obinutuzumab, would outperform